Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Active not recruiting 3Withdrawn 1Unknown 1Terminated 1Recruiting 1Completed 1

Sponsor Class

NIH 4OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1

Conditions

Rectal Neoplasms 1Neoplasms 1Colorectal Neoplasms 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × Sigmoidoscopy × Clear all
NCT04600180 2025-11-25

DEFENCE

University Medical Center Groningen

Active not recruiting
38 enrolled
Tumor-Agnostic

Neoplasms

NCT03955510 2025-10-28

AFT

Rush University Medical Center

Phase NA Active not recruiting
12 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05610163 2025-09-08

JANUS

Alliance for Clinical Trials in Oncology

Phase 2 Active not recruiting
783 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡